News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aprea Therapeutics, Inc. - Common Stock
(NQ:
APRE
)
0.7154
+0.1154 (+19.23%)
Streaming Delayed Price
Updated: 11:01 AM EST, Feb 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Aprea Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
Next >
The market is filled with gapping stocks in Wednesday's session.
↗
Today 10:30 EST
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
January 30, 2026
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
↗
January 30, 2026
Via
Chartmill
In today's session, these stocks are experiencing unusual volume.
↗
January 30, 2026
Via
Chartmill
Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session.
↗
January 30, 2026
Via
Chartmill
Aprea Therapeutics: Q4 Earnings Insights
↗
March 26, 2024
Via
Benzinga
What's going on in today's after hours session
↗
January 29, 2026
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
March 31, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 15, 2024
Via
Benzinga
APRE Stock Earnings: Aprea Therapeutics Beats EPS, Beats Revenue for Q2 2024
↗
August 12, 2024
APRE stock results show that Aprea Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
APRE Stock Earnings: Aprea Therapeutics Beats EPS for Q1 2024
↗
May 14, 2024
APRE stock results show that Aprea Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 04, 2024
Via
Benzinga
APRE Stock Earnings: Aprea Therapeutics Misses EPS, Misses Revenue for Q4 2023
↗
March 26, 2024
APRE stock results show that Aprea Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?
↗
March 11, 2024
FDA clearance for Aprea Therapeutics' APR-1051 IND application, a promising WEE1 kinase inhibitor. Phase 1 trial initiation in 2024, focusing on Cyclin E cancers. $34 million private placement to fund...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
March 11, 2024
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
↗
October 30, 2023
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
↗
September 25, 2023
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
↗
September 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 18, 2023
Via
Benzinga
Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
↗
June 09, 2023
The Dow Jones closed higher by over 160 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
↗
March 10, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
Why Aprea Therapeutics Shares Hit A New 52-Week Low Today
↗
February 23, 2023
Aprea Therapeutics Inc (NASDAQ: APRE) shares are trading lower by 17.59% to $5.20 after the company announced pricing of a $5.5 million underwritten public offering of common stock. What Else?
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
February 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
February 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 11, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Close
